Please use this identifier to cite or link to this item:Volltext verfügbar? / Dokumentlieferung
|Title:||Hepatocellular Carcinoma and Nuclear Paraspeckles : Induction in Chemoresistance and Prediction for Poor Survival|
|Author(s):||Kessler, Sonja M.|
Hussein, Usama Khamis
Kim, Kyoung Min
Schultheiß, Christina S.
Schulz, Marcel H.
Jang, Kyu Yun
|Title:||Cellular Physiology and Biochemistry|
|Publisher/Platform:||Cell Physiol Biochem Press GmbH & Co KG|
|Year of Publication:||2019|
|Place of publication:||Düsseldorf|
|Publikation type:||Journal Article|
|Abstract:||RNA nuclear paraspeckle assembly transcript 1 (NEAT1), localised in nuclear paraspeckles, has been shown to enhance chemoresistance in several cancer types. Since data on NEAT1 in HCC chemosensitivity are completely lacking and chemoresistance is linked to poor prognosis, we aimed to study NEAT1 expression in HCC chemoresistance and its link to HCC prognosis. Methods: NEAT1 expression was determined in either sensitive, or sorafenib, or doxorubicin resistant HepG2, PLC/PRF/5, and Huh7 cells by qPCR. Paraspeckles were detected by immunostaining of paraspeckle component 1 (PSPC1) in cell culture and in a cohort of HCC patients. PSPC1 expression was correlated with clinical data. The expression of transcript variants of NEAT1 and transcripts encoding the paraspeckle-associated proteins was analysed in the TCGA liver cancer data set. Results: NEAT1 was overexpressed in all three sorafenib and doxorubicin resistant cell lines. Paraspeckles were present in all chemoresistant cells, whereas no signal was detected in the sensitive cells. Expression of NEAT1 transcripts as well as transcripts encoding PSPC1, NONO, and RBM14 was increased in tumour tissue. Expression of PSPC1, NONO, and RBM14 transcripts was significantly associated with poor survival, whereas NEAT1 expression was not. Immunohistochemical analysis revealed that nuclear and cytoplasmic PSPC1-positivity was significantly associated with shorter overall survival of HCC patients. Conclusion: Our data show an induction of NEAT1 in HCC chemoresistance and a high correlation of transcripts encoding paraspeckle-associated proteins with poor survival in HCC. Therefore, NEAT1, PSPC1, NONO, and RBM14 might be promising targets for novel HCC therapies, and the paraspeckle-associated proteins might be clinical markers and predictors for poor survival in HCC.|
|DOI of the first publication:||10.33594/000000055|
|Link to this record:||hdl:20.500.11880/27479|
|Date of registration:||11-Jul-2019|
|Faculty:||NT - Naturwissenschaftlich- Technische Fakultät|
|Department:||NT - Pharmazie|
|Collections:||UniBib – Die Universitätsbibliographie|
Files for this record:
There are no files associated with this item.
Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.